FIELD: virology, pharmacology and bioorganic chemistry.
SUBSTANCE: invention relates to the field of virology, pharmacology and bioorganic chemistry, specifically to the use of a substance - N,N'-bis-(2,3-butadienyl)-1,4-diaminobutane dihydrochloride (MDL72.527) - for suppressing the replication of SARS-CoV coronavirus -2. Suppression is carried out by inhibiting the catabolism of biogenic polyamines.
EFFECT: invention can find application in the treatment of a new coronavirus infection caused by SARS-CoV-2.
1 cl, 2 dwg, 1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR USE OF N,N'-BIS(2,3-BUTADIENYL)-1,4-DIAMINOBUTANE DIHYDROCHLORIDE (MDL72.527) FOR SUPPRESSING REPLICATION OF HEPATITIS C VIRUS | 2017 |
|
RU2667123C1 |
| TREATMENT AND/OR PREVENTION OF DISEASE OR SYNDROME ASSOCIATED WITH VIRAL INFECTION | 2021 |
|
RU2823437C2 |
| METHOD FOR PREVENTION OR TREATMENT OF CORONAVIRUS AND OTHER ACUTE RESPIRATORY VIRAL INFECTIONS | 2022 |
|
RU2794315C1 |
| MODIFIED ANTISENSE OLIGONUCLEOTIDE AGAINST SARS-CoV-2 | 2020 |
|
RU2750584C1 |
| USE OF ALCOHOLIC EXTRACT OF AERIAL PARTS OF MARAL ROOT RHAPONTICUM CARTHAMOIDES AS AGENT, INHIBITING ACTIVITY OF CORONAVIRUS SARS-CoV-2 AND HERPES SIMPLEX VIRUS TYPE 2 IN VITRO AND METHOD FOR PRODUCTION THEREOF | 2023 |
|
RU2825393C1 |
| METHOD FOR EARLY DETECTION OF NEUROLOGICAL DISORDERS IN PATIENTS WITH COVID-19 | 2021 |
|
RU2779562C1 |
| LIPOSOMAL COMPOSITION OF 5-CHLOROPYRIDIN-3-IL-1H-INDOL-4-CARBOXYLATE AS A POTENTIAL EMERGENCY PREVENTION AND TREATMENT OF CORONAVIRUS INFECTIONS | 2023 |
|
RU2810261C1 |
| METHOD FOR DETERMINING THE ACTIVITY OF NEUTRALISING ANTIBODIES AGAINST SARS-CoV-2 IN THE SERUM OR PLASMA OF PEOPLE WITH PAST CASES OF COVID-19 OR VACCINATED WITH PREVENTIVE VACCINES AGAINST THE NOVEL CORONAVIRUS INFECTION COVID-19 USING A SET OF ENZYME IMMUNOASSAY REAGENTS CONTAINING A RECOMBINANT RECEPTOR-BINDING DOMAIN (RBD) OF SURFACE GLYCOPROTEIN S OF CORONAVIRUS SARS-CoV-2 AND RECOMBINANT HUMAN RECEPTOR ACE2 | 2021 |
|
RU2784655C1 |
| HERBAL TEA COMPOSITION | 2022 |
|
RU2795879C1 |
| METHOD FOR OBTAINING AN AQUEOUS EXTRACT OF FIREWEED LEAVES EPILOBIUM ANGUSTIFOLIUM L., WHICH EXHIBITS INHIBITORY ACTIVITY AGAINST SARS-CoV-2 CORONAVIRUS AND HERPES SIMPLEX VIRUS TYPE 2 IN VITRO | 2022 |
|
RU2788172C1 |
